KPIs & Operating Metrics(New)
Growth Metrics

Aurora Cannabis (ACB) Current Deferred Revenue (2017 - 2025)

Aurora Cannabis has reported Current Deferred Revenue over the past 9 years, most recently at $1.4 million for Q4 2025.

  • Quarterly Current Deferred Revenue fell 38.96% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, down 38.96% year-over-year, with the annual reading at $748488.3 for FY2025, 40.21% down from the prior year.
  • Current Deferred Revenue was $1.4 million for Q4 2025 at Aurora Cannabis, up from $1.0 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $5.2 million in Q3 2021 and troughed at $748488.3 in Q1 2025.
  • The 5-year median for Current Deferred Revenue is $1.8 million (2022), against an average of $2.2 million.
  • Year-over-year, Current Deferred Revenue soared 221.14% in 2021 and then plummeted 67.08% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $4.4 million in 2021, then plummeted by 53.57% to $2.0 million in 2022, then rose by 26.45% to $2.6 million in 2023, then dropped by 12.39% to $2.2 million in 2024, then crashed by 38.96% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for ACB's Current Deferred Revenue are $1.4 million (Q4 2025), $1.0 million (Q3 2025), and $1.2 million (Q2 2025).